ResearcherGlasgow Royal InfirmaryNo recent work listed

Lavanniya K. P. Velu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110733576. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2015: 1 paper

Papers 1

RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial. Co-author DOI 10.1093/jnci/djv204 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Colin William Steele · 1 shared paper, 2015 · strength 0.05
- Paper RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial. DOI 10.1093/jnci/djv204 ↗
Nigel Balfour Jamieson · 1 shared paper, 2015 · strength 0.05
- Paper RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial. DOI 10.1093/jnci/djv204 ↗
Colin J. McKay · 1 shared paper, 2015 · strength 0.05
- Paper RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial. DOI 10.1093/jnci/djv204 ↗
Donald C. McMillan · 1 shared paper, 2015 · strength 0.05
- Paper RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial. DOI 10.1093/jnci/djv204 ↗
C. Ross Carter · 1 shared paper, 2015 · strength 0.05
- Paper RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial. DOI 10.1093/jnci/djv204 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.